NVG-2089

· Nuvig Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NVG-2089, covering 2025-07-31 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP [Phase 2]